Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ABUS
QDEL
Add up to 3 more stocks
ABUS
Arbutus Biopharma Corp
-4.07%
$4.48-0.19Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$884.97M
52W Range
$3.50 - $5.45
QDEL
QuidelOrtho Corporation
+3.54%
$12.57+0.43Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$857.16M
52W Range
$9.92 - $35.58
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 5.74 | N/A |
| Forward P/E | 6.05 | 16.27 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.42 | 0.48 |
| P/S Ratio | 4.87 | 0.32 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | 5.90 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 44.6% |
| Operating Margin | -192.1% | -30.7% |
| Net Margin | 84.2% | -39.2% |
| ROE | 59.2% | -59.1% |
| ROA | 55.9% | -18.3% |
| ROIC | 54.4% | -16.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 81.42 | 1.39 |
| Quick Ratio | 81.42 | 0.76 |
| Debt/Equity | 0.01 | 1.73 |
| Interest Coverage | -278.88 | -5.18 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.